Cite

HARVARD Citation

    Géhin, M. et al. (n.d.). A novel CRTH2 antagonist: Single‐ and multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ACT‐453859 in healthy subjects. Journal of clinical pharmacology. pp. 787-797. [Online]. 
  
Back to record